NCT02724163 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02724163
Title	International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia (Myechild01)
Acronym	Myechild01
Recruitment	Recruiting
Gender	both
Phase	Phase III
Variant Requirements	No
Sponsors	University of Birmingham
Indications	myelodysplastic syndrome myeloid sarcoma acute myeloid leukemia
Therapies	Gemtuzumab ozogamicin Busulfan + Fludarabine Cytarabine Cytarabine + Fludarabine Cytarabine + Daunoxome Busulfan + Cyclophosphamide Cytarabine + Mitoxantrone
Age Groups:	child
Covered Countries	NZL \| IRL \| GBR \| FRA \| CHE \| AUS

NCT02724163
Clinical Trial Detail